Practice question

Answer the question and get instant feedback.

MediumKDIGO Guideline (2024): Evaluation and Management of Chronic Kidney DiseaseChronic Kidney Diseasediabetic kidney disease

A 66-year-old with CKD G3a A3 (UACR 520 mg/g) and T2DM is on maximally tolerated ACE inhibitor. eGFR 56 mL/min/1.73 m². Which addition most slows kidney disease progression per KDIGO?

Educational content. Not a substitute for clinical judgement or local policy.